Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/16/2013 | 03:34am CEST

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
07:25a KERING : This week, we love to buy…
07:25a WILMAR SUGAR AUSTRALIA : Plane Creek crush starts tomorrow - 19 June 2017 #
07:20a COLLABORATION AT #CLUS : Get Ready to Fly Like a Superhero!
07:08a FEDERAL HOME LOAN MORTGAGE : Fannie, Freddie easing up on appraisal requirements
07:02a Time may be nearing for ECB stimulus exit - Weidmann
06:39a MINISTRY OF ECONOMIC AFFAIRS AND FINANCE OF IS : INTA gains 5k billion tomans via fighting tax evasion
06:38a PRIYANKA CHOPRA : This is how you fight rape stigma - The Standard
06:11a INFOSYS : Automation is the Future of It
06:10a HDFC BANK : CAIT to Organise 100 GST Clinics Across India
06:10a INFOSYS : Finalising System for Capital Allocation Plan
Latest news
Advertisement
Hot News 
18.96%IMAGINATION TECHNOLOGIES : U.K. Chip Designer Puts Itself on Block -- WSJ
-5.33%GLOBAL LOGISTIC PROPERTIES : Says It Remains in Talks With Shortlisted Bidders
-12.28%BlackBerry misses sales forecasts, shares tumble
-1.23%Harley-Davidson Discussing Purchase of Italian Rival Ducati From VW
1.40%BOEING : Is Top Seller at Paris Air Show -- WSJ
Most Read News
06/24 Internal dossier criticises Audi top management - Bild
06/24 BEIJING ENTERPRISES : Anichebe joins Chinese side Beijing Enterprise
06/24 HB GRANDI : A fantastic ship
06/24 IREN : Engineering services
06/24 EXPONENT : 9th International Fresenius Conference – Pesticide Residues in Food
Most recommended articles
06/24 INTERNAL DOSSIER CRITICISES AUDI TOP MANAGEMENT : Bild
06/24 Lufthansa wants to help, not take over, Air Berlin - Bild
06/24DJMARKET SNAPSHOT : Want To Know Where The Stock Market's Headed Over The Next 6 Months? Don't Ask OPEC
06/24 RAYTHEON : CEO of Raytheon's Forcepoint eyes IPO - Boersen-Zeitung
06/24 Volkswagen's Slovak union says close to wage deal to end strike